US FDA takes step to change peptide compounding policy
The US FDA on Thursday submitted a new policy change that could allow pharmacies to more easily compound certain peptides to the White House for consideration.
The US FDA on Thursday submitted a new policy change that could allow pharmacies to more easily compound certain peptides to the White House for consideration.